The First Gene Linked to Scoliosis (CHD7): What It Means for Families

Scientists have identified CHD7 as the first gene linked to scoliosis, marking a breakthrough in understanding its genetic causes. This discovery paves the way for early detection and personalized treatments and potentially reduces the need for surgery. Learn how this research is shaping the future of scoliosis care.

Scoliosis has puzzled physicians since antiquity — Hippocrates described spinal curvature over two thousand years ago — yet for most of that history its cause stayed a mystery. A major step came when researchers identified the first gene clearly linked to idiopathic scoliosis: CHD7. This article explains what that discovery showed, what genetics research has added since, and — most usefully for families — what it does and doesn't mean for a child today.

The Discovery: the CHD7 Gene

A collaborative team — including scientists from Washington University School of Medicine in St. Louis, UT Southwestern, Texas Scottish Rite Hospital for Children, Rutgers and the University of Iowa — identified the CHD7 gene as a contributor to idiopathic scoliosis, the most common form. Their findings were published in the American Journal of Human Genetics and marked the first time a specific gene was tied to the condition.

The study, led by Dr Carol Wise, examined 52 families with scoliosis spanning at least two generations. Using genome-wide scans, the team found a variation in a non-coding (regulatory) region of CHD7 in many patients. Rather than breaking the CHD7 protein outright, this variation subtly reduces the gene's activity — a small change that researchers suggested mirrors the gradual way idiopathic scoliosis tends to develop.

Why CHD7?

The researchers were led to CHD7 by a rare condition called CHARGE syndrome, in which CHD7 is missing or severely disrupted and scoliosis is common among those affected. That clue prompted the hypothesis that milder variations in the same gene might influence the far more common idiopathic scoliosis — which the family study went on to support.

What Genetics Has Added Since

CHD7 was the beginning, not the end, of the story. Since that discovery, large genome-wide association studies have linked several other genes to adolescent idiopathic scoliosis — notably LBX1, along with others such as GPR126/ADGRG6 and POC5. The emerging picture is that idiopathic scoliosis is polygenic: many genes each contribute a small amount, interacting with growth and environmental factors rather than a single “scoliosis gene” switching it on. This is also why scoliosis can run in families without following a simple inheritance pattern.

What This Means for Families Today

It's important to be realistic about where the science stands. These discoveries are genuinely exciting for research, but they have not yet produced a routine genetic test that tells a family whether their child will develop scoliosis or how far a curve will progress. Earlier commercial genetic tests for scoliosis have had limited predictive value and are not part of standard care.

The practical takeaways are more grounded:

  • Genes are a risk factor, not destiny. A family history raises the odds but does not guarantee a child will be affected, and many children with no family history develop scoliosis.
  • Family history is a reason to watch, not to worry. If a parent or sibling has scoliosis, simple regular checks during the growth years are sensible — see our guide to signs of scoliosis in children.
  • What you can act on still matters most. Early detection and monitoring during growth remain the levers families and clinicians actually control — and they shape outcomes far more than genetics alone. Our article on the growing spine explains why timing matters.

How Scoliosis Is Managed Now

Genetic insight will, in time, refine prediction and perhaps therapy. For now, management still rests on proven approaches matched to the individual curve, age and growth stage:

  • Monitoring — tracking the curve over time, including with tools such as a scoliometer, to catch change early.
  • Scoliosis-specific exercise and bracing — for suitable growing curves, supporting alignment and reducing the chance of progression.
  • Surgery — reserved for severe or rapidly progressing curves.

At ScolioLife, the focus is non-surgical management that looks beyond a single number to posture, rotation and growth. The clinical goal is to support healthy spinal development; every case is different and results vary.

Frequently Asked Questions

Is scoliosis genetic?
Genetics clearly play a role — scoliosis often runs in families, and genes including CHD7 and LBX1 have been linked to it — but it is polygenic and influenced by growth and other factors, so it isn't caused by a single gene.

Can I get a genetic test to know if my child will develop scoliosis?
Not reliably. There is no routine, validated genetic test that predicts who will develop idiopathic scoliosis or how a curve will progress. Regular physical monitoring during growth remains the practical approach.

If scoliosis runs in my family, will my child get it?
Not necessarily. A family history increases the likelihood but is not a certainty, and scoliosis also occurs in children with no family history. It's a good reason for regular checks, not for alarm.

What was the significance of the CHD7 discovery?
It was the first gene clearly linked to idiopathic scoliosis, opening the door to understanding the condition's genetic basis and, eventually, better prediction and targeted care.

Take the Next Step

Genetics is steadily explaining why scoliosis develops, but for families the most useful action remains timely, individual assessment — especially where scoliosis runs in the family. Learn more about non-surgical scoliosis management at ScolioLife, or book a personalised assessment. Canadian families usually connect to Singapore via major Asian or Gulf hubs, and many begin with an online consultation. ScolioLife's specialist clinics are in Singapore, Kuala Lumpur and Surabaya, following the same protocol at each. Every case is different and should be individually assessed.